In a research report published Monday, Chardan analyst Gbola Amusa reiterated a Neutral rating on shares of Avalanche Biotechnologies Inc (NASDAQ:AAVL), while reducing the price …
In a research report published Tuesday, Chardan analyst Gbola Amusa upgraded shares of Avalanche Biotechnologies Inc (NASDAQ:AAVL) from Sell to Neutral rating, as his price …
Aerie Pharmaceuticals Inc (NASDAQ:AERI) shares shot up 56% to $20.75 in pre-market trading after the FDA agreed to allow Aerie to change the …
Chardan analyst Gbola Amusa weighed in today with a negative report on Esperion Therapeutics Inc (NASDAQ:ESPR), reducing the price target to $55 (from $50), while reiterating …
In a research report issued today, Chardan Capital analyst Gbola Amusa initiated coverage on shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) with a Buy rating …
In a research report released Friday, Chardan analyst Gbola Amusa initiated coverage on shares of Uniqure NV (NASDAQ:QURE) with a Buy rating and a $40 …
In a research note published after market close today, Chardan Capital analyst Gbola Amusa maintained a Neutral rating on OHR Pharmaceutical Inc (NASDAQ:OHRP) and reduced …
In a research report issued Friday, Chardan Capital analyst Gbola Amusa initiated coverage on shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) with a Buy rating and a price target …
In a research report published Tuesday, Chardan Capital analyst Gbola Amusa reiterated a Buy rating on La Jolla Pharmaceutical Company (NASDAQ:LJPC) with a $54 price …
